Cabot (CBT) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Cabot

NYSE•Basic Materials•Specialty Chemicals

$78.46-0.74(-0.01%)Pre-market

Market Cap

$4.00B

P/E

21.0x

P/S

1.1x

P/B

2.5x

Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through two segments, Reinforcement Materials and Performance Chemicals. The company offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions. It also provides specialty carbons for use in inks, coatings, plastics, adhesives, toners, batteries, and displays; conductive additives and fumed alumina used in lead acid and lithium-ion batteries for electric vehicles; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; and fumed alumina for use in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries. In addition, it offers aerogel, a hydrophobic, silica-based particle to use in various thermal insulation and specialty chemical applications; masterbatch and conductive compound products that are used in automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics industries; and inkjet colorants for inkjet printing applications, as well as carbon nanotubes and fumed metal oxides. The company sells its products through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.

How this company scores

AverageMetricSide Score: 50/100

Strongest: Balance Sheet & Red Flags (19/25); weakest: Growth (5/25).

Profitability12/25

Growth5/25

Balance Sheet & Red Flags19/25

Cash & Earnings Quality14/25

Strengths

Consistent free cash flowImproving leverageNo share dilution

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 21.0x5y range 8.7x – 31.2x

Currently above its 20-quarter median.

P/S · 1.1x5y range 0.8x – 1.5x

Currently near its 20-quarter median.

P/B · 2.5x5y range 2.2x – 4.3x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Watch

Operating margins declined 17.9% — watch for continued compression, which may signal competitive or cost pressure.

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.

Price & Volume

Market Cap $4.00B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $3.63B
Q. Revenue: $982.00M
TTM EBITDA: $750.00M
TTM Op. Income: $493.00M
Q. Op. Income: $98.00M
TTM Net Income: $190.00M
Q. Net Income: $6.00M
EPS: $0.12
Shares Out.: $51.60M

$3.63B in TTM revenue declined 4.7% YoY, reaching $982.00M last quarter. TTM EBITDA of $750.00M and TTM operating income of $493.00M show growth is flowing through to the bottom line. TTM net income of $190.00M means revenue is converting into profit. Over the past year, TTM revenue is down 5% — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 18.7%
EBITDA Margin: 15.1%
Op. Margin: 10.0%
Net Margin: 0.6%

Op. margin of 10.0% is down 8.1% YoY — costs are rising relative to revenue. Net margin at 0.6% and gross margin of 18.7% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has fallen for 4 consecutive quarters — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 21.0x
P/S Ratio: 1.1x
P/B Ratio: 2.5x

At 21.0x P/E, the stock trades within typical market levels. P/S of 1.1x and P/B of 2.5x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 8 quarters, P/E has risen for 2 consecutive quarters — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $3.98B
Cash: $250.00M
Long-Term Debt: $828.00M
Book Value: $1.60B
D/E Ratio: 0.5
Debt/EBITDA: 5.6

With $3.98B in assets and $828.00M in long-term debt, D/E is 0.5and book value is $1.60B — a conservative capital structure with a cushion to weather downturns. Over the past year, debt/equity is down 28% — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $75.00M
TTM Free Cash Flow: $281.00M
FCF Margin: 7.7%
FCF / Net Income: 1.5

TTM FCF of $281.00M on $75.00M in operating cash flow. The FCF / Net Income ratio of 1.5x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is down 19% — a weakening trend.